Persistence Capital Partners signs deal to take Neighbourly Pharmacy private

Advertisement

Advertise with us

TORONTO - Private equity firm Persistence Capital Partners has signed a definitive agreement to buy the stake in Neighbourly Pharmacy Inc. that it does not already own and take the company private.

Read this article for free:


or

Already have an account? Log in here »

To continue reading, please subscribe:

Subscribe and receive a limited-edition Free Press branded hat or tote.

Digital Subscription

One year of digital access for only $205*

  • Enjoy unlimited reading on winnipegfreepress.com
  • Read the E-Edition, our digital replica newspaper
  • Access News Break, our award-winning app
  • Play interactive puzzles

*First annual payment billed as $205.00 + GST for one year. This annual subscription will automatically renew at $233.00 + GST every 52 weeks (10% off the regular annual price of $259.35). Offer available to new and qualified returning subscribers only. Cancel any time.

To continue reading, please subscribe:

Add Free Press access to your Brandon Sun subscription for only an additional

$1 for the first 4 weeks*

  • Enjoy unlimited reading on winnipegfreepress.com
  • Read the E-Edition, our digital replica newspaper
  • Access News Break, our award-winning app
  • Play interactive puzzles
Start now

*Your next Brandon Sun subscription payment will increase by $1.00 and you will be charged $17.95 plus GST for four weeks. After four weeks, your payment will increase to $24.95 plus GST every four weeks.

Hey there, time traveller!
This article was published 15/01/2024 (990 days ago), so information in it may no longer be current.

TORONTO – Private equity firm Persistence Capital Partners has signed a definitive agreement to buy the stake in Neighbourly Pharmacy Inc. that it does not already own and take the company private.

The deal will see PCP, which already owns about a 50 per cent interest in the network of independent pharmacies, pay $18.50 per share for a total of $415 million for the shares it does not already own.

Neighbourly shareholders will also receive a contingent value right worth an additional 61 cents per share for a total of $13.7 million that is payable if it achieves a target for its pro-forma adjusted earnings before interest, taxes, depreciation and amortization for its 2026 financial year.

Prescription drugs are seen on shelves at a pharmacy in Montreal on March 11, 2021. THE CANADIAN PRESS/Ryan Remiorz
Prescription drugs are seen on shelves at a pharmacy in Montreal on March 11, 2021. THE CANADIAN PRESS/Ryan Remiorz

PCP first offered $20.50 per share for Neighbourly in October last year, but cut its offer to $18.50 on Dec. 18 after what it said was difficult market conditions and views from its committed financing sources.

Neighbourly shares closed down 14 cents at $15.75 on the Toronto Stock Exchange on Friday.

The transaction requires approval by a two-thirds majority vote by Neighbourly shareholders and a majority vote by shareholders excluding PCP and its affiliates. The deal is expected to close by March 29, subject to customary conditions.

This report by The Canadian Press was first published Jan. 15, 2024.

Companies in this story: (TSX:NBLY)

Report Error Submit a Tip

Business

LOAD BUSINESS ARTICLES